Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


14.05.2018

16 AIDS
10 AIDS Res Hum Retroviruses
1 Am J Med
1 Antimicrob Agents Chemother
1 BMC Neurol
1 Cell
5 Clin Infect Dis
5 HIV Med
1 J Am Acad Dermatol
1 J Immunol
2 J Infect Dis
1 J Med Virol
8 J Virol
10 Lancet HIV
1 MMWR Morb Mortal Wkly Rep
3 Pediatr Infect Dis J
1 PLoS Med
12 PLoS One
2 PLoS Pathog
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. VITORIA M, Hill A, Ford N, Doherty M, et al
    The transition to dolutegravir and other new antiretrovirals in low- and middle-income countries - what are the issues?
    AIDS. 2018 May 9. doi: 10.1097/QAD.0000000000001845.
    PubMed     Text format     Abstract available

  2. YANG J, Jacobson LP, Becker JT, Levine A, et al
    Impact of glycemic status on longitudinal cognitive performance in men with and without HIV Infection.
    AIDS. 2018 May 8. doi: 10.1097/QAD.0000000000001842.
    PubMed     Text format     Abstract available

  3. CARLANDER C, Wagner P, Beirs AV, Yilmaz A, et al
    Suppressive antiretroviral therapy associates with effective treatment of high-grade cervical intraepithelial neoplasia.
    AIDS. 2018 May 8. doi: 10.1097/QAD.0000000000001853.
    PubMed     Text format     Abstract available

  4. HORVATH S, Phillips N, Heany SJ, Kobor MS, et al
    Perinatally acquired HIV infection accelerates epigenetic aging in South African adolescents.
    AIDS. 2018 May 8. doi: 10.1097/QAD.0000000000001854.
    PubMed     Text format     Abstract available

  5. RUBIN LH, Sacktor N, Creighton J, Du Y, et al
    Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy.
    AIDS. 2018 May 9. doi: 10.1097/QAD.0000000000001858.
    PubMed     Text format     Abstract available

  6. EVANS VA, Van Der Sluis RM, Solomon A, Dantanarayana A, et al
    PD-1 contributes to the establishment and maintenance of HIV-1 latency.
    AIDS. 2018 May 9. doi: 10.1097/QAD.0000000000001849.
    PubMed     Text format     Abstract available

  7. ROJAS J, Blanco JL, Sanchez-Palomino S, Marcos MA, et al
    A maintenance three-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicity: the A-TRI-WEEK pilot trial.
    AIDS. 2018 May 9. doi: 10.1097/QAD.0000000000001843.
    PubMed     Text format     Abstract available

  8. MANICKAM C, Nwanze C, Ram DR, Shah SV, et al
    Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001855.
    PubMed     Text format     Abstract available

  9. HUGHES RA, May MT, Tilling K, Taylor N, et al
    Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001848.
    PubMed     Text format     Abstract available

  10. ADLAND E, Mori L, Laker L, Csala A, et al
    Recovery of effective hiv-specific cd4+ t-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001844.
    PubMed     Text format     Abstract available

  11. INVERNIZZI A, Acquistapace A, Bochicchio S, Resnati C, et al
    Correlation between inner retinal layer thickness and cognitive function in HIV: new insights from an exploratory study.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001850.
    PubMed     Text format     Abstract available

  12. KORHONEN C, Kimani M, Wahome E, Otieno F, et al
    Depressive symptoms and problematic alcohol and other substance use in 1,476 gay, bisexual, and other men who have sex with men at three research sites in Kenya.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001847.
    PubMed     Text format     Abstract available

  13. SERRANO A, El Haddad S, Moal F, Prazuck T, et al
    Dysregulation of apoptosis and autophagy gene expression in PBMCs of efficiently treated HIV-infected patients.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001851.
    PubMed     Text format     Abstract available

  14. JANI IV, Meggi B, Loquiha O, Tobaiwa O, et al
    Effect of point-of-care early infant diagnosis on antiretroviral therapy initiation and retention of patients: a cluster-randomised trial.
    AIDS. 2018 May 8. doi: 10.1097/QAD.0000000000001846.
    PubMed     Text format     Abstract available

  15. CHOW FC, Wilson MR, Wu K, Ellis RJ, et al
    Stroke incidence is highest in women and non-Hispanic blacks living with HIV in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort.
    AIDS. 2018;32:1125-1135.
    PubMed     Text format     Abstract available

  16. DIJKSTRA M, van Lunsen RHW, Kooij KW, Davidovich U, et al
    HIV-1 status is independently associated with decreased erectile function among middle-aged MSM in the era of combination antiretroviral therapy.
    AIDS. 2018;32:1137-1146.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  17. LANDIS RC, Abayomi EA, Bain B, Greene E, et al
    Shifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017.
    AIDS Res Hum Retroviruses. 2018 May 5. doi: 10.1089/AID.2017.0310.
    PubMed     Text format     Abstract available

  18. ROSS LL, Shortino D, Shaefer MS
    Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-associated Mutations from Antiretroviral Therapy-naive, HIV-1-infected Patients in the United States.
    AIDS Res Hum Retroviruses. 2018 May 5. doi: 10.1089/AID.2017.0295.
    PubMed     Text format     Abstract available

  19. JAN M, Tomer S, Arora SK
    alpha(1-6)-fucosylated complex glycan-binding lentil lectin enhances in vitro HIV-1 infection and DC-SIGN-mediated viral capture and transmission to CD4 cells.
    AIDS Res Hum Retroviruses. 2018 May 6. doi: 10.1089/AID.2018.0045.
    PubMed     Text format     Abstract available

  20. DIPHOKO T, Gaseitsiwe S, Kasvosve I, Moyo S, et al
    Prevalence of Rilpivirine and Etravirine resistance mutations in HIV-1 Subtype C- infected patients failing Nevirapine or Efavirenz-based combination antiretroviral therapy in Botswana.
    AIDS Res Hum Retroviruses. 2018 May 6. doi: 10.1089/AID.2017.0135.
    PubMed     Text format     Abstract available

  21. WANG P, Li J, Wang X, Wu GY, et al
    Asymptomatic HIV vertical transmitted adolescents' brain functional changes: based on resting state functional MRI.
    AIDS Res Hum Retroviruses. 2018 May 8. doi: 10.1089/AID.2017.0267.
    PubMed     Text format     Abstract available

  22. RATTO-KIM S, Schuetz A, Sithinamsuwan P, Barber J, et al
    Characterization of Cellular Immune Responses in Thai Individuals with and without HIV-Associated Neurocognitive Disorders.
    AIDS Res Hum Retroviruses. 2018 May 8. doi: 10.1089/AID.2017.0237.
    PubMed     Text format     Abstract available

  23. JANES H, Corey L, Ramjee G, Carpp LN, et al
    Weighing the evidence of efficacy of oral PrEP for HIV prevention in women in southern Africa.
    AIDS Res Hum Retroviruses. 2018 May 6. doi: 10.1089/AID.2018.0031.
    PubMed     Text format     Abstract available

  24. ZHOU Z, Ma P, Feng Y, Ou W, et al
    Characterization of a New HIV-1 CRF01_AE/ CRF07_BC recombinant virus in Tianjin, China.
    AIDS Res Hum Retroviruses. 2018 May 4. doi: 10.1089/AID.2018.0077.
    PubMed     Text format     Abstract available

  25. WANG C, Wang Y, Kong D, Liang S, et al
    Identification of a Novel HIV-1 B/C/ CRF01_AE Recombinant Isolate in Guangxi, China.
    AIDS Res Hum Retroviruses. 2018 May 4. doi: 10.1089/AID.2018.0070.
    PubMed     Text format     Abstract available

  26. WANG JY, Chen XH, Shao B, Huo QQ, et al
    Identification of a new HIV-1 circulating recombinant form CRF65_cpx strain in Jilin, China.
    AIDS Res Hum Retroviruses. 2018 May 4. doi: 10.1089/AID.2018.0086.
    PubMed     Text format     Abstract available


    Am J Med

  27. PAIM AC, Rizza SA, Badley AD, Prieto M, et al
    Transient loss of HIV-1 DNA in an HIV-1 positive patient after kidney transplantation: A case report.
    Am J Med. 2018 May 3. pii: S0002-9343(18)30399.
    PubMed     Text format    


    Antimicrob Agents Chemother

  28. AMMERMAN NC, Swanson RV, Bautista EM, Almeida DV, et al
    Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00636.
    PubMed     Text format     Abstract available


    BMC Neurol

  29. LI RL, Sun J, Tang ZC, Zhang JJ, et al
    Axonal chronic injury in treatment-naive HIV+ adults with asymptomatic neurocognitive impairment and its relationship with clinical variables and cognitive status.
    BMC Neurol. 2018;18:66.
    PubMed     Text format     Abstract available


    Cell

  30. SAJADI MM, Dashti A, Rikhtegaran Tehrani Z, Tolbert WD, et al
    Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses.
    Cell. 2018 Apr 28. pii: S0092-8674(18)30393-3. doi: 10.1016/j.cell.2018.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  31. SIMONSEN L, Higgs E, Taylor RJ, Wentworth D, et al
    Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic.
    Clin Infect Dis. 2018 May 8. pii: 4993975. doi: 10.1093.
    PubMed     Text format     Abstract available

  32. KOSS CA, Ayieko J, Mwangwa F, Owaraganise A, et al
    Early Adopters of HIV Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda.
    Clin Infect Dis. 2018 May 5. pii: 4993212. doi: 10.1093.
    PubMed     Text format     Abstract available

  33. CORNELISSE VJ, Fairley CK, Stoove M, Asselin J, et al
    Evaluation of PrEP eligibility criteria using sexually transmissible infections as HIV risk markers at enrolment in PrEPX, a large Australian HIV pre-exposure prophylaxis trial.
    Clin Infect Dis. 2018 May 7. pii: 4993324. doi: 10.1093.
    PubMed     Text format     Abstract available

  34. OWENS RL, Hicks CB
    A Wake-up Call for Human Immunodeficiency Virus (HIV) Providers: Obstructive Sleep Apnea in People Living With HIV.
    Clin Infect Dis. 2018 May 9. pii: 4994301. doi: 10.1093.
    PubMed     Text format     Abstract available

  35. LUONG NGUYEN LB, Yazdanpanah Y, Maman D, Wanjala S, et al
    Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness.
    Clin Infect Dis. 2018 May 8. pii: 4994303. doi: 10.1093.
    PubMed     Text format     Abstract available


    HIV Med

  36. CROXFORD S, Yin Z, Kall M, Burns F, et al
    Where do we diagnose HIV infection? Monitoring new diagnoses made in nontraditional settings in England, Wales and Northern Ireland.
    HIV Med. 2018 May 9. doi: 10.1111/hiv.12627.
    PubMed     Text format     Abstract available

  37. BROWN AE, Attawell K, Hales D, Rice BD, et al
    Monitoring the HIV continuum of care in key populations across Europe and Central Asia.
    HIV Med. 2018 May 8. doi: 10.1111/hiv.12603.
    PubMed     Text format     Abstract available

  38. JAKOBSEN SF, Raben D, Sperle I, Lazarus JV, et al
    Scale-up of HIV self-testing.
    HIV Med. 2018 May 8. doi: 10.1111/hiv.12618.
    PubMed     Text format    

  39. GONZALEZ-CORDON A, Domenech M, Camafort M, Martinez-Rebollar M, et al
    Subclinical cardiovascular disease in patients starting contemporary protease inhibitors.
    HIV Med. 2018 May 10. doi: 10.1111/hiv.12619.
    PubMed     Text format     Abstract available

  40. AHMED SI, Hasan SS, Babar MG
    Patients' involvement in the care process: time to value nontraditional indicators in HIV care.
    HIV Med. 2018 May 10. doi: 10.1111/hiv.12620.
    PubMed     Text format    


    J Am Acad Dermatol

  41. BOOZALIS E, Tang O, Patel S, Semenov YR, et al
    Ethnic differences and comorbidities of 909 Prurigo Nodularis patients.
    J Am Acad Dermatol. 2018 May 4. pii: S0190-9622(18)30655.
    PubMed     Text format     Abstract available


    J Immunol

  42. KIANI Z, Dupuy FP, Bruneau J, Lebouche B, et al
    HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1.
    J Immunol. 2018 May 9. pii: jimmunol.1701370. doi: 10.4049/jimmunol.1701370.
    PubMed     Text format     Abstract available


    J Infect Dis

  43. NALWOGA A, Cose S, Nash S, Miley W, et al
    Relationship between Anaemia, Malaria Co-infection and Kaposi Sarcoma-associated Herpesvirus (KSHV) Seropositivity in a Population-based Study in Rural Uganda.
    J Infect Dis. 2018 May 8. pii: 4993751. doi: 10.1093.
    PubMed     Text format     Abstract available

  44. CHAN P, Patel P, Hellmuth J, Colby DJ, et al
    Distribution of HIV RNA in CSF and Blood is linked to CD4/CD8 Ratio During Acute HIV.
    J Infect Dis. 2018 May 7. pii: 4993332. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  45. NICOT F, Jeanne N, Raymond S, Delfour O, et al
    Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene.
    J Med Virol. 2018 May 11. doi: 10.1002/jmv.25224.
    PubMed     Text format     Abstract available


    J Virol

  46. QIAO J, Cao Y, Zabaleta J, Yang L, et al
    Regulation of virus-associated lymphoma growth and gene expression by bacterial quorum sensing molecules.
    J Virol. 2018 May 9. pii: JVI.00478-18. doi: 10.1128/JVI.00478.
    PubMed     Text format     Abstract available

  47. ELSAYED H, Nabi G, McKinstry WJ, Khoo KK, et al
    Intrastructural Help: Harnessing T-Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines.
    J Virol. 2018 May 9. pii: JVI.00141-18. doi: 10.1128/JVI.00141.
    PubMed     Text format     Abstract available

  48. JI S, Na L, Ren H, Wang Y, et al
    Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
    J Virol. 2018 May 9. pii: JVI.00499-18. doi: 10.1128/JVI.00499.
    PubMed     Text format     Abstract available

  49. MAHDI M, Szojka Z, Motyan JA, Tozser J, et al
    Inhibitory effects of HIV-2 Vpx on replication of HIV-1.
    J Virol. 2018 May 9. pii: JVI.00554-18. doi: 10.1128/JVI.00554.
    PubMed     Text format     Abstract available

  50. LODERMEYER V, Ssebyatika G, Passos V, Ponnurangam A, et al
    The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K is Species-Specific.
    J Virol. 2018 May 9. pii: JVI.00226-18. doi: 10.1128/JVI.00226.
    PubMed     Text format     Abstract available

  51. SCINTO HB, Gupta S, Thorat S, Mukhtar MM, et al
    A novel strategy to adapt SHIV-E1 carrying env from an RV144 volunteer to rhesus macaques: coreceptor switch and final recovery of a pathogenic virus with exclusive R5 tropism.
    J Virol. 2018 May 9. pii: JVI.02222-17. doi: 10.1128/JVI.02222.
    PubMed     Text format     Abstract available

  52. MUELLER N, Pasternak AO, Klaver B, Cornelissen M, et al
    The HIV-1 Tat protein enhances splicing at the major splice donor site.
    J Virol. 2018 May 9. pii: JVI.01855-17. doi: 10.1128/JVI.01855.
    PubMed     Text format     Abstract available

  53. WENSEL D, Sun Y, Davis J, Li Z, et al
    A Novel gp41-Binding Adnectin with Potent Anti-HIV Activity Is Highly Synergistic when Linked to a CD4-Binding Adnectin.
    J Virol. 2018 May 9. pii: JVI.00421-18. doi: 10.1128/JVI.00421.
    PubMed     Text format     Abstract available


    Lancet HIV

  54. HAYWARD P
    Highlights of the 25th CROI.
    Lancet HIV. 2018;5:e209.
    PubMed     Text format    

  55. MCGETTRICK PMC, Mallon PWG
    HIV and cardiovascular disease: defining the unmeasured risk.
    Lancet HIV. 2018 May 3. pii: S2352-3018(18)30061.
    PubMed     Text format    

  56. THE LANCET HIV
    Will Redfield's HIV background prepare him for top CDC job?
    Lancet HIV. 2018;5:e199.
    PubMed     Text format    

  57. MOLINA JM, Grund B
    Prioritisation of subgroups for immediate antiretroviral therapy - Authors' reply.
    Lancet HIV. 2018;5:e206.
    PubMed     Text format    

  58. WU Z, Zhao Y, McGoogan J
    Prioritisation of subgroups for immediate antiretroviral therapy.
    Lancet HIV. 2018;5:e206.
    PubMed     Text format    

  59. RYOM L, Lundgren JD, El-Sadr W, Reiss P, et al
    Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.
    Lancet HIV. 2018 May 3. pii: S2352-3018(18)30043.
    PubMed     Text format     Abstract available

  60. KIRBY T
    UK sexual health services struggle with public health cuts.
    Lancet HIV. 2018;5:e207-e208.
    PubMed     Text format    

  61. KIRBY T, Thornber-Dunwell M
    Dean Street clinics-battling London's MSM HIV epidemic.
    Lancet HIV. 2018;5:e210.
    PubMed     Text format    

  62. SHIAU S, Abrams EJ, Arpadi SM, Kuhn L, et al
    Early antiretroviral therapy in HIV-infected infants: can it lead to HIV remission?
    Lancet HIV. 2018;5:e250-e258.
    PubMed     Text format     Abstract available

  63. PENAZZATO M, Watkins M, Morin S, Lewis L, et al
    Catalysing the development and introduction of paediatric drug formulations for children living with HIV: a new global collaborative framework for action.
    Lancet HIV. 2018;5:e259-e264.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  64. BIXLER D, Corby-Lee G, Proescholdbell S, Ramirez T, et al
    Access to Syringe Services Programs - Kentucky, North Carolina, and West Virginia, 2013-2017.
    MMWR Morb Mortal Wkly Rep. 2018;67:529-532.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  65. RUISENOR-ESCUDERO H, Sikorskii A, Familiar-Lopez I, Persaud D, et al
    Neruodevelopmental Outcomes in Pre-School Children Living with HIV-1 Subtypes A and D in Uganda.
    Pediatr Infect Dis J. 2018 May 9. doi: 10.1097/INF.0000000000002097.
    PubMed     Text format     Abstract available

  66. YEGANEH N, Watts DH, Xu J, Kerin T, et al
    Infectious Morbidity, Mortality and Nutrition in HIV-Exposed, Uninfected, Formula Fed Infants: Results from the HPTN 040/PACTG 1043 Trial.
    Pediatr Infect Dis J. 2018 May 10. doi: 10.1097/INF.0000000000002082.
    PubMed     Text format     Abstract available

  67. GOODENOUGH CJ, Patel K, Van Dyke RB
    Is there a Higher Risk of Mother-to-Child Transmission of HIV Among Pregnant Women with Perinatal HIV Infection?
    Pediatr Infect Dis J. 2018 May 4. doi: 10.1097/INF.0000000000002084.
    PubMed     Text format     Abstract available


    PLoS Med

  68. DESMONDE S, Tanser F, Vreeman R, Takassi E, et al
    Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    PLoS Med. 2018;15:e1002565.
    PubMed     Text format     Abstract available


    PLoS One

  69. KUNKLER B, Salamango D, DeBruine ZJ, Ploch C, et al
    CUL5 is required for thalidomide-dependent inhibition of cellular proliferation.
    PLoS One. 2018;13:e0196760.
    PubMed     Text format     Abstract available

  70. BUMGARDNER SA, Zhang L, LaVoy AS, Andre B, et al
    Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platform.
    PLoS One. 2018;13:e0196950.
    PubMed     Text format     Abstract available

  71. KENYON CR, Wolfs K, Osbak K, van Lankveld J, et al
    Implicit attitudes to sexual partner concurrency vary by sexual orientation but not by gender-A cross sectional study of Belgian students.
    PLoS One. 2018;13:e0196821.
    PubMed     Text format     Abstract available

  72. SAJJADI H, Jorjoran Shushtari Z, Shati M, Salimi Y, et al
    An indirect estimation of the population size of students with high-risk behaviors in select universities of medical sciences: A network scale-up study.
    PLoS One. 2018;13:e0195364.
    PubMed     Text format     Abstract available

  73. PADMASAWITRI TIA, Frederix GW, Alisjahbana B, Klungel O, et al
    Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review.
    PLoS One. 2018;13:e0193293.
    PubMed     Text format     Abstract available

  74. OLADELE RO, Toriello C, Ogunsola FT, Ayanlowo OO, et al
    Prior subclinical histoplasmosis revealed in Nigeria using histoplasmin skin testing.
    PLoS One. 2018;13:e0196224.
    PubMed     Text format     Abstract available

  75. RUPEREZ M, Noguera-Julian M, Gonzalez R, Maculuve S, et al
    HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique.
    PLoS One. 2018;13:e0196451.
    PubMed     Text format     Abstract available

  76. OFFOR O, Utay N, Reynoso D, Somasunderam A, et al
    Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy.
    PLoS One. 2018;13:e0196395.
    PubMed     Text format     Abstract available

  77. MULU W, Yizengaw E, Alemu M, Mekonnen D, et al
    Pharyngeal colonization and drug resistance profiles of Morraxella catarrrhalis, Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae among HIV infected children attending ART Clinic of Felegehiwot Referral Hospital, Ethiopia.
    PLoS One. 2018;13:e0196722.
    PubMed     Text format     Abstract available

  78. DIABATE S, Chamberland A, Geraldo N, Tremblay C, et al
    Gonorrhea, Chlamydia and HIV incidence among female sex workers in Cotonou, Benin: A longitudinal study.
    PLoS One. 2018;13:e0197251.
    PubMed     Text format     Abstract available

  79. HOGAN LE, Hanhauser E, Hobbs KS, Palmer CD, et al
    Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation.
    PLoS One. 2018;13:e0197298.
    PubMed     Text format     Abstract available

  80. GONZALEZ RG, Fell R, He J, Campbell J, et al
    Temporal/compartmental changes in viral RNA and neuronal injury in a primate model of NeuroAIDS.
    PLoS One. 2018;13:e0196949.
    PubMed     Text format     Abstract available


    PLoS Pathog

  81. ROTEM E, Faingold O, Charni M, Klug YA, et al
    The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice.
    PLoS Pathog. 2018;14:e1007044.
    PubMed     Text format     Abstract available

  82. SCHIFFNER T, Pallesen J, Russell RA, Dodd J, et al
    Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins.
    PLoS Pathog. 2018;14:e1006986.
    PubMed     Text format     Abstract available


    Virology

  83. BOWDER D, Thompson J, Durst K, Hollingsead H, et al
    Characterization of twin-cysteine motif in the V2-loop region of gp120 in primate lentiviruses.
    Virology. 2018;519:180-189.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: